Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diindolylmethane (DIM) Dietary Supplementation: A Nonsurgical Treatment for Cervical Intraepithelial Neoplasia (CIN)

NCT00212381 is registered in ClinicalTrials.gov with New York Presbyterian Hospital as lead sponsor.

NCT NCT00212381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diindolylmethane (DIM) Dietary Supplementation: A Nonsurgical Treatment for Cervical Intraepithelial Neoplasia (CIN)
Lead sponsor
New York Presbyterian Hospital
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2000
Completion date
July 31, 2010
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dysplasia